FCMI
Foresite Capital Management IV Portfolio holdings
AUM
$124M
1-Year Return
24.36%
This Quarter Return
+5.39%
1 Year Return
-24.36%
3 Year Return
+1.86%
5 Year Return
+16.17%
10 Year Return
–
AUM
$198M
AUM Growth
+$40.5K
(+0.02%)
Cap. Flow
+$0
Cap. Flow
% of AUM
0%
Top 10 Holdings %
Top 10 Hldgs %
100%
Holding
5
New
–
Increased
–
Reduced
–
Closed
–
Top Buys
No buys this quarter
Top Sells
No sells this quarter
Sector Composition
| 1 | Healthcare | 100% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1
Pharvaris
PHVS
$1.4B
| $93.3M | 47.16% |
4,038,842
| – | – |
|
2
Kura Oncology
KURA
$707M
| $39.5M | 19.94% |
1,849,947
| – | – |
|
|
KNTE
3
DELISTED
Kinnate Biopharma Inc. Common Stock
KNTE
| $25.7M | 13% |
9,671,643
| – | – |
|
4
Syndax Pharmaceuticals
SNDX
$1.41B
| $20.8M | 10.52% |
875,000
| – | – |
|
5
Lyell Immunopharma
LYEL
$250M
| $18.6M | 9.38% |
416,250
| – | – |
|